|Save ComparisonClear all|
KinDex was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease.
Syndesi Therapeutics is a belgium based developing molecules and biotech company.
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
Vtesse's lead compound, VTS-270, has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease.
Seattle, US HQ
Ottignies-Louvain-la-Neuve, BE HQ
Waltham, US HQ
Cambridge, US HQ
Gaithersburg, US HQ
Latest funding round
Latest funding round$ 327.3k (almost 2 years ago)
Latest funding round$ 21.1m (7 months ago)
Latest funding round$ 51.5m (about 2 years ago)
Latest funding round$ 50m (about 2 years ago)
Latest funding round$ 17m (about 2 years ago)
Total funding raised
Total funding raised$ 5.8m
Total funding raised$ 21.1m
Total funding raised$ 51.5m
Total funding raised$ 50m
Total funding raised$ 67m